Growth Factors and Polycystic Ovarian Syndrome

Seminars in Reproductive Endocrinology

Volumn 14, Issue 3, 1996, Pages 203-208

  Giudice, Linda C ^a   Morales, Arlene J ^b   Yen, Samuel S S C ^b  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH PROMOTOR; SOMATOMEDIN;

FEMALE; HUMAN; OBESITY; OVARY POLYCYSTIC DISEASE; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

FEMALE; GROWTH SUBSTANCES; HUMANS; OBESITY; POLYCYSTIC OVARY SYNDROME; SOMATOMEDINS;

EID: 0030204088     PISSN: 07348630     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1016330     Document Type: Article

References (42)

1. Adashi EY, Rohan M: Intraovarian regulation peptidergic signaling systems. Trends Endocrinol Metab 3:243-248, 1992
2. Giudice LC: The insulin-like growth factor system in normal and abnormal human ovarian follicle development. Am J Med 98(1A):48S-54S, 1995
3. Yen SSC, Laughlin GA, Morales AJ: Interface between extra-and intraovarian factors in polycystic ovarian syndrome. NY Acad Sci 687:98, 1993
4. Barbieri RL, Smith S, Ryan KJ: The role of hyperinsulinemia in the pathogenesis of ovarian hyperandrogenism. Fertil Steril 50:197-203, 1988
5. Stuart CA, Nagamani M: Insulin infusion acutely augments ovarian androgen production in normal women. Fertil Steril 54:788-792, 1990
6. Stuart CA, Prince MJ, Peters EJ, et al: Hyperinsulinemia and hyperandrogenism: In vivo androgen response to insulin infusion. Obstet Gynecol 69:921-925, 1987
7. Pasquali R, Casimirri F: The impact of obesity on hyperandrogenism and polycystic ovary syndrome in premenopausal women. Clin Endocrinol 39:1-16, 1993
8. Nestler JE, Clore JN, Blackard WG: The central role of obesity (hyperinsulinemia) in the pathogenesis of the polycystic ovary syndrome. Am J Obstet Gynecol 161:1095, 1989
9. Barreca A, Artini PG, DelMonte P, et al: In vivo and in vitro effects of growth hormone on estradiol secretion by human granulosa cells. J Clin Endocrinol Metab 77:61-67, 1993
10. Mason HD, Martikainen H, Beard RW, Anyaoku V, Franks S: Direct gonadotrophic effect of growth hormone on oestradiol production by human granulosa cells in vitro. J Endocrinol 126:R1-R4, 1990
11. Katz E, Ricciarelli E, Adashi E: The potential of growth hormone to female reproductive physiology and pathophysiology. Fertil Steril 59:8-34, 1993
12. Sharara FI, Nieman LK: Identification and cellular localization of growth hormone receptor gene expression in the human ovary. J Clin Endocrinol Metab 79:670-672, 1994
13. El-Roeiy A, Chen X, Roberts VJ, LeRoith D, Roberts CT, Yen SSC: Expression of the insulin-like growth factor (IGF)-I and IGF-II and the IGF-I, IGF-II and insulin receptor genes and localization of the gene products in the human ovary. J Clin Endocrinol Metab 77:1411-1418, 1993
14. Zhou J, Bondy C: Anatomy of the human ovarian insulin-like growth factor system. Biol Repro 48:467-482, 1993
15. El-Roeiy A, Roberts VJ, Shimasaki S, et al: Expression of the gene encoding the insulin-like growth factors (IGF-I and IGF-II), the IGF and insulin receptors and IGF binding proteins (IGFBPs 1-6), and the localization of their gene products in normal and polycystic ovary syndrome ovaries. J Clin Endocrinol Metab 78:1488-1496, 1994
16. Yen SSC: The polycystic ovary syndrome. Clin Endocrinol 12:177, 1980
17. Franks S: Polycystic ovary syndrome: A changing perspective. Clin Endocrinol 31:87-120, 1989
18. Kopelman PG: Hormones and obesity. Clin Endocrinol Metab 8:549-575, 1994
19. Grulet H, Hecart AC, Delemer B, et al: Roles of LH and insulin resistance in lean and obese polycystic ovary syndrome. Clin Endocrinol 38:621-626, 1993
20. Holte J, Bergh T, Gennarelli G, Wide L: The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women. Clin Endococrinol 41:473-481, 1994
21. Laatikainen T, Tulenheimo A, Andersson B, Karkkainen J: Obesity, serum steroid levels, and pulsatile gonadotropin secretion in polycystic ovarian disease. Eur J Obstet Gynecol Reprod Biol 15:45-53, 1983
22. Dale PO, Tanbo T, Vaaler S, Abyholm T: Body weight, hyperinsulinemia, and gonadotropin levels in the polycystic ovarian syndrome: Evidence of two distinct populations. Fertil Steril 58:487-491, 1992
23. Poretsky L: Insulin resistance and hyperandrogenism: Update 1995. Endocrine Rev 2:125-129, 1994
24. Antilla L, Koskinen P, Jaatinen TA, et al: Insulin hypersecretion together with high luteinizing hormone concentrations augments androgen secretion in oral glucose tolerance test in women with polycystic ovarian disease. Hum Reprod 8:1179-1183, 1993
25. Kazer RR, Unterman TG, Glick RP: An abnormality of the growth hormone/insulin-like growth factor I axis in women with polycystic ovary syndrome. J Clin Endocrinol Metab 71:958-962, 1990
26. Prevelic GM, Wurzburger MI, Balint-Peric I, Ginsburg J: Twenty-four hour serum growth hormone, insulin, C-peptide and blood glucose profiles and serum insulin-like growth factor-1 concentrations in women with polycystic ovaries. Horm Res 37:125-131, 1992
27. Insler V, Barash A, Shohanm A, et al: Overnight secretion pattern of growth hormone, sex hormone binding globulin, insulin-like growth factor-I and its binding protein in obese and non-obese women with polycystic ovarian disease. Isr J Med Sci 30:42-47, 1994
28. Slowinska-Srzednicka J, Zgliczynski W, Makowska A, et al: An abnormality of the growth hormone/insulin-like growth factor-1 axis in women with polycystic ovary syndrome due to coexistent obesity. J Clin Endocrinol Metab 74:1432-1435, 1992
29. Morales AJ, Laughlin GA, Bützow T, Maheshwari H, Baumann G, Yen SSC: Insulin, somatotrophic and LH axes in lean and obese women with polycystic ovary syndrome (PCOS): Common and distinct features. J Clin Endocrinol Metab, in press
30. Poretsky L, Peiper B: Insulin resistance, hypersecretion of LH, and a dual-defect hypothesis for the pathogenesis of polycystic ovary syndrome. Obstet Gynecol 84:613-621, 1994
31. Willis D, Franks S: Insulin action in human granulosa cells from normal and polycystic ovaries is mediated by the insulin receptor and not the type I insulin-like growth factor receptor. J Clin Endocrinol Metab 80:3788-3790, 1996
32. Dunaif A, Segal KR, Shelley D, Green G, Dobrjansky A, Licholai T: Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome. Diabetes 41:1257-1265, 1992
33. Willis D, Mason H, Gilling-Smith GS, Franks S: Modulation by insulin of follicle-stimulating hormone and luteinizing hormone actions in human granulosa cells of normal and polycystic ovaries. J Clin Endocrinol Metab 81:302-309, 1996
34. van Dessel HJHM T, Yap OW, Chandrasekher YA, Fauser BCJM, Giudice LC: Ovarian follicular fluid levels of insulin-like growth factor (IGF)-I, IGF-II, and IGF binding proteins-1 and -3 during the follicular phase of the normal menstrual cycle. J Clin Endocrinol Metab 81:1224-1231, 1996
35. van Dessel HJHM T, Chandrasekher YA, Yap OW, Fauser BCJM, Giudice LC: IGF binding protein-1 is decreased and free IGF-I is increased in the circulation of women with polycystic ovarian syndrome. Amer Soc Reprod Med Abstr 1996
36. Mason HD, Cwyfan-Hughes SC, Heinrich G, Franks S, Holly JMP: Insulin-like growth factor (IGF) I and II, IGF binding proteins, and IGF-binding protein proteases are produced by theca and stroma of normal and polycystic human ovaries. J Clin Endocrinol Metab 81:276-284, 1996
37. Suikkari A-M, Tiitinen A, Stenman U-H, Seppala M, Laatikainen T: Oral contraceptives increase insulin-like growth factor binding protein concentration in women with polycystic ovarian disease. Fertil Steril 55:895-899, 1991
38. Mason HD, Willis DS, Beard RW, Winston RML, Margara R, Franks S: Estradiol production by granulosa cells of normal and polycystic ovaries: Relationship to menstrual cycle history and concentrations of gonadotropins and sex teroids in follicular fluid. J Clin Endocrinol Metab 79:1355-1360, 1994
39. Cataldo NA, Giudice LC: Insulin-like growth factor binding protein profiles in follicular fluid in polycystic ovarian syndrome. J Clin Endocrinol Metab 74:695-697, 1992
40. Cataldo NA, Giudice LC: Insulin-like growth factor binding protein profiles in human ovarian follicular fluid correlate with follicular functional status. J Clin Endocrinol Metab 74:821-829, 1992
41. Chandrasekher YA, van Dessel JHJM, Fauser BCJM, Giudice LC: Estrogen- but not androgen-dominant human ovarian follicular fluid contains an insulin-like growth factor binding prtoein-4 protease. J Clin Endocrinol Metab 80:2734-2739, 1995
42. Yap OWS, Chandrasekher YA, van Dessel TJHM, Fauser BJCM, Giudice LC: Similar insulin-like growth factor binding protein profiles in androgen-dominant follicular fluid from normal, polycystic ovary syndrome, and androgen-treated female-to male transsexual human ovaries. (Submitted for publication)